FDA Approvals & Updates

25 Oct 2016 9:01 AM | Lori Aubrey (Administrator)
  • Pembrolizumab for NSCLC - PD-L1
  • Olaratumab accelerated approval for STS

Comments

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software